Results 61 to 70 of about 21,682 (247)

Erythema nodosum as Leprosy reaction

open access: yesVestnik Dermatologii i Venerologii, 2020
Purpose.To present a clinical case of leprosy exacerbation on the background of ongoing therapy. Materials and methods.A 52-year-old patient with a diagnosis of "lepromatous (cutaneous) leprosy, leprosy LL" (multi-bacterial leprosy, lepromatous form ...
Viktoria G. Semenova   +2 more
doaj   +1 more source

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 495-502, February 2026.
Abstract Extraintestinal manifestations (EIMs) manifest in 6%‐47% of patients with inflammatory bowel disease (IBD). Here, we characterize the course of EIMs in pediatric patients receiving vedolizumab included in the VedoKids cohort study. This was a subgroup analysis of the pediatric VedoKids cohort, a multicenter, prospective study of children (aged
Giulia D'Arcangelo   +11 more
wiley   +1 more source

Highly suspected valsartan-induced chronic erythema nodosum migrans in a patient with hypertension: a case report

open access: yesJournal of International Medical Research, 2022
Erythema nodosum migrans (ENM) is usually considered as a rare clinical variant of erythema nodosum and is characterized by unilateral, migratory, relatively painless, nodular lesions.
Yong Liu   +3 more
doaj   +1 more source

Variation in the prevalence of enteropathogenic Yersinia in slaughter pigs from Belgium, Italy, and Spain [PDF]

open access: yes, 2011
Tonsils of 829 fattening pigs originating from Belgium (n = 201), Italy (n = 428), and Spain (n 200) were collected between 2005 and 2007 to study the prevalence of enteropathogenic Yersinia in slaughter pigs.
Fredriksson-Ahomaa, Maria   +5 more
core   +1 more source

TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background While tumor necrosis factor (TNF) inhibitors can induce paradoxical reactions, sarcoidosis‐like disease has hardly been reported so far. This study aimed to describe the epidemiological, diagnostic and therapeutic features of TNF inhibitor‐induced sarcoidosis‐like lesions in patients with inflammatory bowel disease.
Zlata Chkolnaia   +12 more
wiley   +1 more source

Acute pancreatitis as the first manifestation of duodenal MALT lymphoma

open access: yesBiomedical Papers, 2015
Background: Possibly any tumor that can cause mechanical obstruction of the distal bile duct can induce acute pancreatitis. However, acute pancreatitis as the first clinical manifestation of duodenal lymphoma is extremely rare.
Ivona Simkova   +7 more
doaj   +1 more source

Increased expression of IL-22 is associated with disease activity in Behcet's disease. [PDF]

open access: yesPLoS ONE, 2013
OBJECTIVE: Interleukin (IL)-22 has been reported to be involved in the development of autoimmune diseases. This study aimed to analyze the expression and potential role of IL-22 in the pathogenesis of Behcet's disease (BD).
Tao Cai   +7 more
doaj   +1 more source

New‐onset autoimmune disease following SARS‐CoV‐2 infection and mRNA vaccination in Norway: A retrospective cohort study

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 271-282, February 2026.
Abstract Background Studies suggest an increase in autoimmune diseases following SARS‐CoV‐2 infection and/or COVID‐19‐vaccination. We aimed to describe possible associations in Norway. Methods We used information from the emergency preparedness register for COVID‐19, BeredtC19, for all residents aged 18–64 (N = 3,450,080).
Håkon Bøås   +4 more
wiley   +1 more source

Lobular panniculitis: A manifestation of pancreatic tumor with fatal outcome [PDF]

open access: yes, 2005
Lobular panniculitis is a skin condition that may be the first sign of underlying pancreatic disease. Though rare, the condition has been sufficiently well defined and pathognomonic, thus making differentiation from idiopathic lobular panniculitis quite ...
Brkić Silvija   +6 more
core   +1 more source

Outcomes of an Intravenous to Subcutaneous Infliximab (CT‐P13) Strategy in Takayasu Arteritis: A Proof‐of‐Concept Prospective Study

open access: yesACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objectives To evaluate persistence, outcomes, safety, and remission maintenance after switching from intravenous infliximab (IV‐IFX) to subcutaneous infliximab (SC‐IFX, CT‐P13) in patients with Takayasu arteritis (TA). Methods We conducted a prospective, single‐center, proof‐of‐concept observational study of consecutive adults with TA in sustained ...
Luca Iorio   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy